Your browser doesn't support javascript.
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic.
Nimgaonkar, Vivek; Aggarwal, Charu; Berman, Abigail T; Gabriel, Peter; Shulman, Lawrence N; Kucharczuk, John; Roy, Megan; Bauml, Joshua M; Singh, Aditi P; Cohen, Roger B; Langer, Corey J; Marmarelis, Melina E.
  • Nimgaonkar V; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Aggarwal C; Division of Hematology and Oncology, Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Berman AT; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Gabriel P; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Shulman LN; Division of Hematology and Oncology, Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Kucharczuk J; Division of Thoracic Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Roy M; Division of Hematology and Oncology, Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Bauml JM; Division of Hematology and Oncology, Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Singh AP; Division of Hematology and Oncology, Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Cohen RB; Division of Hematology and Oncology, Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Langer CJ; Division of Hematology and Oncology, Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Marmarelis ME; Division of Hematology and Oncology, Department of Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Melina.Marmarelis@pennmedicine.upenn.edu.
BMC Cancer ; 21(1): 1094, 2021 Oct 11.
Article in English | MEDLINE | ID: covidwho-1463236
ABSTRACT

BACKGROUND:

To ensure safe delivery of oncologic care during the COVID-19 pandemic, telemedicine has been rapidly adopted. However, little data exist on the impact of telemedicine on quality and accessibility of oncologic care. This study assessed whether conducting an office visit for thoracic oncology patients via telemedicine affected time to treatment initiation and accessibility.

METHODS:

This was a retrospective cohort study of patients with thoracic malignancies seen by a multidisciplinary team during the first surge of COVID-19 cases in Philadelphia (March 1 to June 30, 2020). Patients with an index visit for a new phase of care, defined as a new diagnosis, local recurrence, or newly discovered metastatic disease, were included.

RESULTS:

240 distinct patients with thoracic malignancies were seen 132 patients (55.0%) were seen initially in-person vs 108 (45.0%) via telemedicine. The majority of visits were for a diagnosis of a new thoracic cancer (87.5%). Among newly diagnosed patients referred to the thoracic oncology team, the median time from referral to initial visit was significantly shorter amongst the patients seen via telemedicine vs. in-person (median 5.0 vs. 6.5 days, p < 0.001). Patients received surgery (32.5%), radiation (24.2%), or systemic therapy (30.4%). Time from initial visit to treatment initiation by modality did not differ by telemedicine vs in-person surgery (22 vs 16 days, p = 0.47), radiation (27.5 vs 27.5 days, p = 0.86, systemic therapy (15 vs 13 days, p = 0.45).

CONCLUSIONS:

Rapid adoption of telemedicine allowed timely delivery of oncologic care during the initial surge of the COVID19 pandemic by a thoracic oncology multi-disciplinary clinic.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: Thoracic Neoplasms / Telemedicine / Pandemics / Time-to-Treatment / COVID-19 / Health Services Accessibility Subject: Thoracic Neoplasms / Telemedicine / Pandemics / Time-to-Treatment / COVID-19 / Health Services Accessibility Type of study: Determinantes_sociais_saude / Observational study / Risk factors Language: English Journal: BMC Cancer Clinical aspect: Etiology Year: 2021

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: Thoracic Neoplasms / Telemedicine / Pandemics / Time-to-Treatment / COVID-19 / Health Services Accessibility Subject: Thoracic Neoplasms / Telemedicine / Pandemics / Time-to-Treatment / COVID-19 / Health Services Accessibility Type of study: Determinantes_sociais_saude / Observational study / Risk factors Language: English Journal: BMC Cancer Clinical aspect: Etiology Year: 2021
...